Detalhe da pesquisa
1.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756902
2.
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
J Clin Oncol
; 40(35): 4119-4128, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759733
3.
Fertility preserving options in patients with gynecologic malignancies.
Am J Obstet Gynecol
; 205(2): 103-10, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21411052
4.
Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study.
Gynecol Oncol
; 113(1): 52-6, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19193428
5.
Colposcopy to evaluate abnormal cervical cytology in 2008.
Am J Obstet Gynecol
; 200(5): 472-80, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19375565
6.
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
J Clin Oncol
; 37(26): 2317-2328, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216226
7.
Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
Cancer Res
; 65(8): 3243-8, 2005 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15833856
8.
Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer.
Clin Cancer Res
; 10(24): 8538-43, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15623636
9.
Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
Obstet Gynecol
; 102(1): 156-61, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12850623
10.
Hormone replacement and breast cancer risk: reconsidering the data.
Oncology (Williston Park)
; 23(12): 1099-100; author reply 1100, 1102, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20017294
11.
Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
J Reprod Med
; 48(10): 756-60, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14619640
12.
NRG Oncology research opportunities within the new National Clinical Trials Network.
Semin Oncol
; 41(5): 553-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25440601
13.
Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis.
Gynecol Oncol
; 104(3): 636-41, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17095080
14.
Predicting parametrial involvement in endometrial cancer: is this the end for radical hysterectomies in stage II endometrial cancers?
Obstet Gynecol
; 116(5): 1016-7, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20966681
15.
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
Gynecol Oncol
; 99(1): 20-5, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16055178
16.
Clinicopathologic features of six cases of primary cervical lymphoma.
Am J Obstet Gynecol
; 193(3 Pt 1): 866-72, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16150291
17.
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
Gynecol Oncol
; 96(1): 204-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15589602
18.
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.
Gynecol Oncol
; 98(3): 360-8, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16000215
19.
Treatment of ovarian cancer: new strategies.
Gynecol Oncol
; 90(2 Pt 2): S24-32, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12928003
20.
Hormone replacement therapy for survivors of breast and endometrial cancer.
Curr Oncol Rep
; 4(2): 152-8, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11822987